S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 0.612 DKK Market Closed
Market Cap: 23.5m DKK

Net Margin
Stenocare A/S

-1 763%
Current
-707%
Average
5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 763%
=
Net Income
-32.8m
/
Revenue
1.9m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
DK
Stenocare A/S
CSE:STENO
23.4m DKK
-1 763%
US
Eli Lilly and Co
NYSE:LLY
722.9B USD
23%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
359B USD
24%
DK
Novo Nordisk A/S
CSE:NOVO B
2.1T DKK
35%
CH
Roche Holding AG
SIX:ROG
206.2B CHF
14%
CH
Novartis AG
SIX:NOVN
185.9B CHF
24%
UK
AstraZeneca PLC
LSE:AZN
161.7B GBP
14%
US
Merck & Co Inc
NYSE:MRK
200.1B USD
27%
IE
Endo International PLC
LSE:0Y5F
163.5B USD
-126%
US
Pfizer Inc
NYSE:PFE
136.3B USD
13%

Stenocare A/S
Glance View

Market Cap
23.4m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.138 DKK
Overvaluation 77%
Intrinsic Value
Price
S
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 763%
=
Net Income
-32.8m
/
Revenue
1.9m
What is the Net Margin of Stenocare A/S?

Based on Stenocare A/S's most recent financial statements, the company has Net Margin of -1 763%.

Back to Top